FDA Inspection
CSL Behring L.L.C.CSL Behring L.L.C. – FDA Inspection, Jul 28, 2014
Record Details
This FDA Inspection record concerns CSL Behring L.L.C., with an inspection on July 28, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- CSL Behring L.L.C.
- Inspection Date
- July 28, 2014
- Product Type
- Drugs
View Company Profile
ID · 7dda7ea5-907a-4cc4-b66b-8769e926ea77
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 888122
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Behring L.L.C.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| June 25, 2026 | Not classified | Chicago District Office | |
| March 2, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 23, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 18, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Behring L.L.C.
- FDA Inspection 1284730 - 2026-06-25
- FDA Inspection 1202268 - 2023-03-02
- FDA Inspection 1153026 - 2021-09-24
- FDA Inspection 1090775 - 2019-05-23
- FDA Inspection 1072948 - 2018-10-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.